These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 19419857

  • 1. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
    Vassal G.
    Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
    [Abstract] [Full Text] [Related]

  • 2. Draft EU regulation on paediatric medicines: some improvements but still far from perfect.
    Prescrire Int; 2006 Feb; 15(81):32-3. PubMed ID: 16548115
    [Abstract] [Full Text] [Related]

  • 3. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D.
    Int J Pharm; 2014 Aug 05; 469(2):240-3. PubMed ID: 24613178
    [Abstract] [Full Text] [Related]

  • 4. The European Regulation on medicines for paediatric use.
    Dunne J.
    Paediatr Respir Rev; 2007 Jun 05; 8(2):177-83. PubMed ID: 17574163
    [Abstract] [Full Text] [Related]

  • 5. European perspectives on pediatric formulations.
    Breitkreutz J.
    Clin Ther; 2008 Nov 05; 30(11):2146-54. PubMed ID: 19108802
    [Abstract] [Full Text] [Related]

  • 6. More than 5 years of European Paediatric Regulation: statistics and industrial experience.
    Winzenburg G.
    Int J Pharm; 2014 Aug 05; 469(2):260-2. PubMed ID: 24704106
    [Abstract] [Full Text] [Related]

  • 7. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB, Smyth RL.
    IDrugs; 2008 Jul 05; 11(7):502-7. PubMed ID: 18600597
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Are children getting the right drugs?].
    Bratlid D.
    Tidsskr Nor Laegeforen; 2005 Dec 01; 125(23):3290-2. PubMed ID: 16327857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K.
    Clin Ther; 2014 Feb 01; 36(2):163-77. PubMed ID: 24529288
    [Abstract] [Full Text] [Related]

  • 15. [New EU law--an improvement for Norwegian children?].
    Kalikstad B.
    Tidsskr Nor Laegeforen; 2009 Sep 10; 129(17):1770-2. PubMed ID: 19756062
    [No Abstract] [Full Text] [Related]

  • 16. [Drug development in paediatric oncology].
    Benninger-Döring G, Boos J.
    Klin Padiatr; 2006 Sep 10; 218(3):152-6. PubMed ID: 16688671
    [Abstract] [Full Text] [Related]

  • 17. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation.
    Pignatti F, Gravanis I, Herold R, Vamvakas S, Jonsson B, Marty M.
    Clin Cancer Res; 2011 Aug 15; 17(16):5220-5. PubMed ID: 21844037
    [Abstract] [Full Text] [Related]

  • 18. The economics of pediatric formulation development for off-patent drugs.
    Milne CP, Bruss JB.
    Clin Ther; 2008 Nov 15; 30(11):2133-45. PubMed ID: 19108801
    [Abstract] [Full Text] [Related]

  • 19. Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al.
    Smith MA, Anderson BD.
    Eur J Cancer; 2004 Aug 15; 40(12):1893-5. PubMed ID: 15288292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.